Original Articles

The Effect of Tumor Size on Oncologic Outcomes in Pathological T2 Stage Renal Cell Carcinoma Patients
  • Dr. Nurullah Hamidi
  • Dr. Evren Süer
  • Dr. İlker Gökçe
  • Dr. Yaşar Bedük
  • Dr. Sümer Baltacı
Bull Urooncol 2017; 16: 1-3 DOI: 10.4274/uob.780
Survival and the Factors of Predict Survival in Non-Clear Cell Renal Cell Carcinoma Cases Which Have Been Undergone Nephron Sparing Surgery
  • Nurullah Hamidi
  • Evren Süer
  • Mehmet İlker Gökçe
  • Sümer Baltacı
  • Yaşar Bedük
Bull Urooncol 2015; 14: 79-82 DOI: 10.4274/uob.214
Should We Perform Thoracic Imaging for Every Patient with a Renal Mass?
  • Ahmet Şahan
  • Asgar Garayev
  • Murat Akgül
  • Tarık Emre Sener
  • Serdar Evman
  • Hasan Batirel
  • Emine Bas Bozkurtlar
  • Rengin Ahıskalı
  • Levent Türkeri
  • İlker Tinay
Bull Urooncol 2016; 15: 90-93 DOI: 10.4274/uob.678
The Presence and Thickness of Pseudocapsule after Partial Nephrectomy in Renal Cell Carcinoma
  • Fehmi Narter
  • Fatih Tarhan
  • Emre Çamur
  • Şükran Sarıkaya
  • Kayhan Başak
  • Murat Tuncer
  • İstem Köse
  • Aydın Özgül
Bull Urooncol 2016; 15: 136-139 DOI: 10.4274/uob.704

Review

  • Sait Sen
Bull Urooncol 2007; 6: 7-16
Renal Cell Carcinoma with venous trombosis: Surgical management
  • Şevket Tolga Tombul
  • Bülent Akdoğan
Bull Urooncol 2011; 10: 32-35
Surgery in metastatic renal cell carcinoma
  • Volkan İzol
  • Bülent Soyupak
Bull Urooncol 2011; 10: 36-40
Paraneoplastic Syndromes in Renal Cell Carcinoma
  • Volkan İzol
  • Eyüp Kaplan
Bull Urooncol 2014; 13: 130-134 DOI: 10.4274/uob.77
Risk Factors and Etiology in Renal Cell Carcinoma
  • Ümit Gül
Bull Urooncol 2014; 13: 135-138 DOI: 10.4274/uob.78
Adjuvant and Neoadjuvant Targeted Therapies in Locally Advanced Renal Cell Carcinoma
  • Ozan Bozkurt
  • Ömer Demir
Bull Urooncol 2014; 13: 139-145 DOI: 10.4274/uob.82
The role of surgery in renal cell carcinoma metastasis
  • Levent Mert Günay
  • Mehmet Cemil Uygur
Bull Urooncol 2013; 12: 147-150
Fuhrman Nuclear Grading System Overview in Renal Cell Carcinoma
  • Oğuz Özden Cebeci
  • Tayyar Alp Özkan
  • Ahmet Tuğrul Eruyar
Bull Urooncol 2014; 13: 157-160 DOI: 10.4274/uob.107
Most frequently seen side effects of targeted therapy: how to manage?
  • Önder Kara
  • Bülent Akdoğan
Bull Urooncol 2013; 12: 179-185
Molecular Fundamentals of the Revolution in the Treatment of Renal Cell Carcinoma
  • Ece Konaç
  • Sinan Sözen
Bull Urooncol 2015; 14: 181-187 DOI: 10.4274/uob.312
The Current Radiological Approach to Renal Cell Carcinoma
  • Nuray Voyvoda
  • Bekir Voyvoda
  • Ömür Memik
Bull Urooncol 2015; 14: 188-192 DOI: 10.4274/uob.352
RCC and lymphadenectomy
  • Serdar Çelik
  • Ozan Bozkurt
  • Uğur Mungan
Bull Urooncol 2013; 12: 205-209
Staging of renal cell carcinoma: 2010 TNM classification system and validation in Turkey
  • Tayyar Alp Özkan
  • Kürşat Yıldız
  • Özdal Dillioğlugil
Bull Urooncol 2012; 11: 206-211
Lymph Node Dissection and Adrenalectomy in Locally Advanced Renal Cell Carcinoma
  • Burak Çitamak
  • Emrullah Sögütdelen
  • Bülent Akdogan
Bull Urooncol 2015; 14: 207-209 DOI: 10.4274/uob.411
Targeted Therapies in Advanced Renal Cell Cancer
  • Sinan Karaaslan
Bull Urooncol 2015; 14: 210-213 DOI: 10.4274/uob.396
Impact of Renal Ischemia on Renal Failure After Partial Nephrectomy
  • Yavuz Selim Süral
  • Ahmet Çag Çal
Bull Urooncol 2015; 14: 219-222 DOI: 10.4274/uob.412
Open partial nephrectomy: recent situation
  • İyimser Üre
  • Sinan Sözen
Bull Urooncol 2012; 11: 225-229
Approach to renal cell carcinoma with vena cava and adrenal involvement and interpretation of data of Turkey by 2012
  • Mehmet İlker Gökçe
Bull Urooncol 2012; 11: 234-239
Neoadjuvant targeted therapy in renal cell carcinoma
  • Sertaç Yazıcı
  • Halil Kızılöz
  • Haluk Özen
Bull Urooncol 2012; 11: 240-245
Morphologic and Molecular Charecteristics of Renal Tumors
  • Sait Şen
Bull Urooncol 2015; 14: 278-284 DOI: 10.4274/uob.495
Quality of Life of Patients with Advanced/Metastatic Renal Cell Carcinoma During the Treatment Period with Targeted Drugs
  • Sinharib Çitgez
Bull Urooncol 2015; 14: 321-323 DOI: 10.4274/uob.460

Article - Comment

Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (Clinical Stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome
  • Semih Ayan
Bull Urooncol 2006; 5: 19-20
The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma:
  • Ali Ihsan Arik
Bull Urooncol 2007; 6: 23-25
Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience
  • Gökhan Temeltas
Bull Urooncol 2006; 5: 23-24
Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up
  • Özgür Yaycioglu
Bull Urooncol 2007; 6: 26-28
Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience
  • Semih Ayan
Bull Urooncol 2007; 6: 30-31
Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate
  • Yildirim Bayazit
Bull Urooncol 2006; 5: 31-33
Fuhrman grading is not appropriate for chromophobe renal cell carcinoma
  • Kutsal Yörükoglu
Bull Urooncol 2007; 6: 37-38
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas
  • Sinan Başay
  • Cemil Uygur
Bull Urooncol 2008; 7: 38-42
Surgical resection of renal cell carcinoma after targeted therapy
  • Asıf Yıldırım
Bull Urooncol 2009; 8: 77-81
Impact of venous tumour thrombus consistency (solid vs friable) on cancer-specific survival in patients with renal cell carcinoma
  • Hakan Akdere
  • Uğur Kuyumcuoğlu
Bull Urooncol 2012; 11: 256-259

Case Report

T1a Papiller Renal Cell Carcinom Case with a Lymph Node Metastasis
  • Mete Özkidik
  • Ömer Gülpinar
  • Evren Süer
  • Mehmet Ilker Gökçe
  • Adil Hüseyinov
  • Sümer Baltaci
Bull Urooncol 2015; 14: 243-244 DOI: 10.4274/uob.346

About Journal

Forms

Useful Links

Applications